Brief: Immunotech Lab to market potential ebola treatment
Oct 21 (Reuters) - Immunotech Laboratories Inc IMMB.PK :
* Enters into agreement to market potential ebola virus disease ("evd")
treatment and implement strategy for company's itv-1 infectious diseases
treatment in Africa
* Source text for Eikon ID:nBw8QDwnsa
* Further company coverage IMMB.PK
((Bangalore Newsroom; +1 646 223 8780))
Recent news on Immunotech Laboratories
See all newsEbola becomes latest stock scam, U.S. SEC says (updated)
Ebola becomes latest stock scam, U.S. SEC says (updated)
Ebola becomes latest stock scam, U.S. SEC says
Brief: SEC suspends trading in companies touting operations related to prevention or treatment of ebola
Brief: Immunotech Lab to market potential ebola treatment